Molecular biomarkers are commonly used for the management of several types of malignant tumours in routine clinical practice. However, this is not the case for malignant gliomas. Cytokines and Angiogenesis factors are potential candidates due to their intrinsic role in tumourigenesis. Pre- and post-operative serum from 36 malignant glioma patients and 36 controls was analysed using the Bio-Plex Pro Angiogenesis and Cytokines Assay (Bio-Rad, USA). Amongst the molecules tested, the serum concentration of follistatin was significantly higher in patients than in controls. Moreover, the serum concentration of follistatin of the patients postoperatively was significantly reduced compared to that preoperatively. Factors such as age and gender did not affect the concentrations of follistatin measured in the serum of patients pre- and post-operatively as well as healthy controls. This is the first report of follistatin as potential biomarker for the detection of malignant gliomas.
Kilpatrick, E.S. (2008) Haemoglobin A1c in the Diagnosis and Monitoring of Diabetes Mellitus. Journal of Clinical Pathology, 61, 977-982. http://www.ncbi.nlm.nih.gov/pubmed/18755721 http://dx.doi.org/10.1136/jcp.2007.054304
Drevs, J. and Schneider, V. (2006) The Use of Vascular Biomarkers and Imaging Studies in the Early Clinical Development of Anti-Tumour Agents Targeting Angiogenesis. Journal of Internal Medicine, 260, 517-529. http://www.ncbi.nlm.nih.gov/pubmed/17116002 http://dx.doi.org/10.1111/j.1365-2796.2006.01727.x
Falzarano, S.M., Ferro, M., Bollito, E., Klein, E.A., Carrieri, G. and Magi-Galluzzi, C. (2015) Novel Biomarkers and Genomic Tests in Prostate Cancer: A Critical Analysis. Minerva Urologica e Nefrologica, 67, 211-231. http://www.ncbi.nlm.nih.gov/pubmed/26054411
Elzek, M.A. and Rodland, K.D. (2015) Proteomics of Ovarian Cancer: Functional Insights and Clinical Applications. Cancer and Metastasis Reviews, 34, 83-96. http://www.ncbi.nlm.nih.gov/pubmed/25736266 http://dx.doi.org/10.1007/s10555-014-9547-8
Mustafa, G.M., Larry, D., Petersen, J.R. and Elferink, C.J. (2015) Targeted Proteomics for Biomarker Discovery and Validation of Hepatocellular Carcinoma in Hepatitis C Infected Patients. World Journal of Hepatology, 7, 1312-1324. http://www.ncbi.nlm.nih.gov/pubmed/26052377 http://dx.doi.org/10.4254/wjh.v7.i10.1312
Louis, D.N., Ohgaki, H., Wiestler, O.D., Cavenee, W.K., Burger, P.C., Jouvet, A., Scheithauer, B.W. and Kleihues, P. (2007) The 2007 WHO Classification of Tumours of the Central Nervous System. Acta Neuropathologica, 114, 97-109. http://www.ncbi.nlm.nih.gov/pubmed/17618441 http://dx.doi.org/10.1007/s00401-007-0243-4
Kleihues, P. and Ohgaki, H. (1999) Primary and Secondary Glioblastomas: From Concept to Clinical Diagnosis. Journal of Neuro-Oncology, 1, 44-51. http://www.ncbi.nlm.nih.gov/pubmed/11550301 http://dx.doi.org/10.1215/15228517-1-1-44
Benjamin, R., Capparella, J. and Brown, A. (2003) Classification of Glioblastoma Multiforme in Adults by Molecular Genetics. The Cancer Journal, 9, 82-90. http://www.ncbi.nlm.nih.gov/pubmed/12784873 http://dx.doi.org/10.1097/00130404-200303000-00003
Grant, R., Collie, D. and Counsell, C. (1996) The Incidence of Cerebral Glioma in the Working Population: A Forgotten Cancer? British Journal of Cancer, 73, 252-254. http://www.ncbi.nlm.nih.gov/pubmed/8546915 http://dx.doi.org/10.1038/bjc.1996.44
http://seer.cancer.gov/statfacts/html/brain.html
Vanan, M.I. and Eisenstat, D.D. (2014) Management of High-Grade Gliomas in the Pediatric Patient: Past, Present, and Future. Neuro-Oncology Practice, 1, 145-157. http://www.ncbi.nlm.nih.gov/pubmed/26034626
Gilbert, M.R., Armstrong, T.S., Pope, W.B., van den Bent, M.J. and Wen, P.Y. (2014) Facing the Future of Brain Tumor Clinical Research. Clinical Cancer Research, 20, 5591-5600. http://www.ncbi.nlm.nih.gov/pubmed/25398842 http://dx.doi.org/10.1158/1078-0432.CCR-14-0835
Ilhan-Mutlu, A., Wagner, L., Wöhrer, A., Furtner, J., Widhalm, G., Marosi, C. and Preusser, M. (2012) Plasma MicroRNA-21 Concentration May Be a Useful Biomarker in Glioblastoma Patients. Cancer Investigation, 30, 615-621. http://www.ncbi.nlm.nih.gov/pubmed/22891879
Skog, J., Würdinger, T., van Rijn, S., Meijer, D.H., Gainche, L., Sena-Esteves, M., Curry Jr., W.T., Carter, B.S., Krichevsky, A.M. and Breakefield, X.O. (2008) Glioblastoma Microvesicles Transport RNA and Proteins That Promote Tumour Growth and Provide Diagnostic Biomarkers. Nature Cell Biology, 10, 1470-1476. http://www.ncbi.nlm.nih.gov/pubmed/19011622 http://dx.doi.org/10.1038/ncb1800
Chan, Q.K., Ngan, H.Y., Ip, P.P., Liu, V.W., Xue, W.C. and Cheung, A.N. (2009) Tumor Suppressor Effect of Follistatin-Like 1 in Ovarian and Endometrial Carcinogenesis: A Differential Expression and Functional Analysis. Carcinogenesis, 30, 114-121. http://www.ncbi.nlm.nih.gov/pubmed/18796737 http://dx.doi.org/10.1093/carcin/bgn215
Chang, K.P., Kao, H.K., Liang, Y., Cheng, M.H., Chang, Y.L., Liu, S.C., Lin, Y.C., Ko, T.Y., Lee, Y.S., Tsai, C.L., Wang, T.H., Hao, S.P. and Tsai, C.N. (2010) Overexpression of Activin A in Oral Squamous Cell Carcinoma: Association with Poor Prognosis and Tumor Progression. Annals of Surgical Oncology, 17, 1945-1956. http://www.ncbi.nlm.nih.gov/pubmed/20309641 http://dx.doi.org/10.1245/s10434-010-0926-2
Ogino, H., Yano, S., Kakiuchi, S., Muguruma, H., Ikuta, K., Hanibuchi, M., Uehara, H., Tsuchida, K., Sugino, H. and Sone, S. (2008) Follistatin Suppresses the Production of Experimental Multiple-Organ Metastasis by Small Cell Lung Cancer Cells in Natural Killer Cell-Depleted SCID Mice. Clinical Cancer Research, 14, 660-667. http://www.ncbi.nlm.nih.gov/pubmed/18245525 http://dx.doi.org/10.1158/1078-0432.CCR-07-1221
Zhao, W., Han, H.B. and Zhang, Z.Q. (2011) Suppression of Lung Cancer Cell Invasion and Metastasis by Connexin43 Involves the Secretion of Follistatin-Like 1 Mediated via Histone Acetylation. The International Journal of Biochemistry & Cell Biology, 43, 1459-1468. http://www.ncbi.nlm.nih.gov/pubmed/21718795 http://dx.doi.org/10.1016/j.biocel.2011.06.009
Sakamoto, Y., Shintani, Y., Harada, K., Abe, M., Shitsukawa, K. and Saito, S. (1996) Determination of Free Follistatin Levels in Sera of Normal Subjects and Patients with Various Diseases. European Journal of Endocrinology, 135, 345-351. http://www.ncbi.nlm.nih.gov/pubmed/8890727 http://dx.doi.org/10.1530/eje.0.1350345
Evans, L.W., Muttukrishna, S. and Groome, N.P. (1998) Development, Validation and Application of an Ultra-Sensitive Two-Site Enzyme Immunoassay for Human Follistatin. Journal of Endocrinology, 156, 275-282. http://www.ncbi.nlm.nih.gov/pubmed/9518873 http://dx.doi.org/10.1677/joe.0.1560275
Kettel, L.M., De Paolo, L.V., Morales, A.J., Apter, D., Ling, N. and Yen, S.S. (1996) Circulating Levels of Follistatin from Puberty to Menopause. Fertility and Sterility, 65, 472-476. http://www.ncbi.nlm.nih.gov/pubmed/8774272
Wakatsuki, M., Shintani, Y., Abe, M., Liu, Z.H., Shitsukawa, K. and Saito, S. (1996) Immunoradiometric Assay for Follistatin: Serum Immunoreactive Follistatin Levels in Normal Adults and Pregnant Women. Journal of Clinical Endocrinology & Metabolism, 81, 630-634. http://www.ncbi.nlm.nih.gov/pubmed/8636280
Widera, C., Horn-Wichmann, R., Kempf, T., Bethmann, K., Fiedler, B., Sharma, S., Lichtinghagen, R., Leitolf, H., Ivandic, B., Katus, H.A., Giannitsis, E. and Wollert, K.C. (2009) Circulating Concentrations of Follistatin-Like 1 in Healthy Individuals and Patients with Acute Coronary Syndrome as Assessed by an Immunoluminometric Sandwich Assay. Clinical Chemistry, 55, 1794-1800. http://www.ncbi.nlm.nih.gov/pubmed/19574466 http://dx.doi.org/10.1373/clinchem.2009.129411
Laboratories, B.-R. (2010) Bio-Plex Pro Cytokine, Chemokine, and Growth Factors Assays. Instruction Manual.
Kim, H.O., Kim, H.S., Youn, J.C., Shin, E.C. and Park, S. (2011) Serum Cytokine Profiles in Healthy Young and Elderly Population Assessed Using Multiplexed Bead-Based Immunoassays. Journal of Translational Medicine, 9, 113. http://www.ncbi.nlm.nih.gov/pubmed/21774806 http://dx.doi.org/10.1186/1479-5876-9-113
http://www.r-project.org/
http://dinmanlab.umd.edu/statistics/tutorial.html
Shapiro, S.S. and Wilk, M.B. (1965) An Analysis of Variance Test for Normality (Complete Samples). Biometrika, 52, 591-611. http://dx.doi.org/10.1093/biomet/52.3-4.591
Student (1908) The Probable Error of a Mean. Biometrika, 6, 1-25. http://dx.doi.org/10.1093/biomet/6.1.1
Carmeliet, P. (2003) Angiogenesis in Health and Disease. Nature Medicine, 9, 653-660. http://www.ncbi.nlm.nih.gov/pubmed/12778163 http://dx.doi.org/10.1038/nm0603-653
Carmeliet, P. (2005) Angiogenesis in Life, Disease and Medicine. Nature, 438, 932-936. http://www.ncbi.nlm.nih.gov/pubmed/16355210 http://dx.doi.org/10.1038/nature04478
Folkman, J. (2007) Angiogenesis: An Organizing Principle for Drug Discovery? Nature Reviews Drug Discovery, 6, 273-286. http://www.ncbi.nlm.nih.gov/pubmed/17396134 http://dx.doi.org/10.1038/nrd2115
Gratzl, M. and Dahl, G. (1976) Ca2+-Induced Fusion of Golgi-Derived Secretory Vesicles Isolated from Rat Liver. FEBS Letters, 62, 142-145. http://www.ncbi.nlm.nih.gov/pubmed/1253976 http://dx.doi.org/10.1016/0014-5793(76)80038-5
Wesseling, P., Ruiter, D.J. and Burger, P.C. (1997) Angiogenesis in Brain Tumors; Pathobiological and Clinical Aspects. Journal of Neuro-Oncology, 32, 253-265. http://www.ncbi.nlm.nih.gov/pubmed/9049887 http://dx.doi.org/10.1023/A:1005746320099
Fischer, I., Gagner, J.P., Law, M., Newcomb, E.W. and Zagzag, D. (2005) Angiogenesis in Gliomas: Biology and Molecular Pathophysiology. Brain Pathology, 15, 297-310. http://www.ncbi.nlm.nih.gov/pubmed/16389942 http://dx.doi.org/10.1111/j.1750-3639.2005.tb00115.x
Mobasheri, A. (2012) Osteoarthritis Year 2012 in Review: Biomarkers. Osteoarthritis Cartilage, 20, 1451-1464. http://www.ncbi.nlm.nih.gov/pubmed/22842200
Yano, A., Fujii, Y., Iwai, A., Kageyama, Y. and Kihara, K. (2006) Glucocorticoids Suppress Tumor Angiogenesis and in Vivo Growth of Prostate Cancer Cells. Clinical Cancer Research, 12, 3003-3009. http://www.ncbi.nlm.nih.gov/pubmed/16707595 http://dx.doi.org/10.1158/1078-0432.CCR-05-2085
Greenberger, S., Boscolo, E., Adini, I., Mulliken, J.B. and Bischoff, J. (2010) Corticosteroid Suppression of VEGF-A in Infantile Hemangioma-Derived Stem Cells. The New England Journal of Medicine, 362, 1005-1013. http://www.ncbi.nlm.nih.gov/pubmed/20237346 http://dx.doi.org/10.1056/NEJMoa0903036
Kawakami, S., Fujii, Y. and Winters, S.J. (2001) Follistatin Production by Skin Fibroblasts and Its Regulation by Dexamethasone. Molecular and Cellular Endocrinology, 172, 157-167. http://www.ncbi.nlm.nih.gov/pubmed/11165049 http://dx.doi.org/10.1016/S0303-7207(00)00371-3
Machein, M.R., Kullmer, J., Ronicke, V., Machein, U., Krieg, M., Damert, A., Breier, G., Risau, W. and Plate, K.H. (1999) Differential Downregulation of Vascular Endothelial Growth Factor by Dexamethasone in Normoxic and Hypoxic Rat Glioma Cells. Neuropathology and Applied Neurobiology, 25, 104-112. http://www.ncbi.nlm.nih.gov/pubmed/10215998 http://dx.doi.org/10.1046/j.1365-2990.1999.00166.x
Nauck, M., Karakiulakis, G., Perruchoud, A.P., Papakonstantinou, E. and Roth, M. (1998) Corticosteroids Inhibit the Expression of the Vascular Endothelial Growth Factor Gene in Human Vascular Smooth Muscle Cells. European Journal of Pharmacology, 341, 309-315. http://www.ncbi.nlm.nih.gov/pubmed/9543253 http://dx.doi.org/10.1016/S0014-2999(97)01464-7
Xu, W., Guo, T., Zhang, Y., Jiang, X., Zhang, Y., Zen, K., Yu, B. and Zhang, C.Y. (2011) The Inhibitory Effect of Dexamethasone on Platelet-Derived Growth Factor-Induced Vascular Smooth Muscle Cell Migration through Up-Regulating PGC-1alpha Expression. Experimental Cell Research, 317, 1083-1092. http://www.ncbi.nlm.nih.gov/pubmed/20955697 http://dx.doi.org/10.1016/j.yexcr.2010.10.006
Bergers, G. and Benjamin, L.E. (2003) Tumorigenesis and the Angiogenic Switch. Nature Reviews Cancer, 3, 401-410. http://www.ncbi.nlm.nih.gov/pubmed/12778130 http://dx.doi.org/10.1038/nrc1093
Berse, B., Brown, L.F., Van de Water, L., Dvorak, H.F. and Senger, D.R. (1992) Vascular Permeability Factor (Vascular Endothelial Growth Factor) Gene Is Expressed Differentially in Normal Tissues, Macrophages, and Tumors. Molecular Biology of the Cell, 3, 211-220. http://www.ncbi.nlm.nih.gov/pubmed/1550962 http://dx.doi.org/10.1091/mbc.3.2.211
Lee, J.K., Hong, Y.J., Han, C.J., Hwang, D.Y. and Hong, S.I. (2000) Clinical Usefulness of Serum and Plasma Vascular Endothelial Growth Factor in Cancer Patients: Which Is the Optimal Specimen? International Journal of Oncology, 17, 149-152. http://www.ncbi.nlm.nih.gov/pubmed/10853032
Lieb, W., Safa, R., Benjamin, E.J., Xanthakis, V., Yin, X., Sullivan, L.M., Larson, M.G., Smith, H.M., Vita, J.A., Mitchell, G.F., Sawyer, D.B. and Vasan, R.S. (2009) Vascular Endothelial Growth Factor, Its Soluble Receptor, and Hepatocyte Growth Factor: Clinical and Genetic Correlates and Association with Vascular Function. European Heart Journal, 30, 1121-1127. http://www.ncbi.nlm.nih.gov/pubmed/19223316 http://dx.doi.org/10.1093/eurheartj/ehp007